Verified email-pattern data for Exegiline is currently limited. You can still use the company insights and contact sections below.
Exegiline is developing a novel oral drug, MT-31, for the treatment of the symptoms related to Alzheimer’s Disease. MT-31 structure combines Rivastigmine (Exelon) with Rasagiline’s (Azilect) propargyl moiety having unique beneficial properties. MT-31, its derivatives and indication, are protected by a recently granted US and EP patents.
Company Details
- Employees
- 1
- Industry
- Pharmaceutical Manufacturing
- Website
- http://www.Exegiline.com
- Keywords
- ELDA AI.
Exegiline Questions
Exegiline's website is http://www.Exegiline.com
Exegiline's LinkedIn profile is https://www.linkedin.com/company/exegiline
Exegiline has
1 employees.
View email and phone details for 1
employees at Exegiline.
Exegiline's industry is
Pharmaceutical Manufacturing
Exegiline's top competitors are
Neurohelp,
Cogme,
Novotalk,
Topicx,
Innereye,
Modulight Biotherapeutics,
Elda Ai,
Cogaid,
Neurogenesis Bio Inc.,
Recallcue.
Exegiline's categories are Pharmaceutical Manufacturing
Explore related pages
Related company profiles:
Companies like Exegiline
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.